Clinical trials: Arthritic Psoriasis

Psoriasis, Arthritic

A Study of Ixekizumab in Participants With Active Psoriatic Arthritis

• Completed
• Age: 18 years and older
• Phase 3
• Injection or infusion
• Results posted

This study will assess the safety and efficacy of ixekizumab (LY2439821) compared to placebo in participants with active psoriatic arthritis.

Trial name

SPIRIT-P1 (NCT01695239)

Testing

Ixekizumab, Adalimumab

Where

116 sites in United States, Belgium and 13 more

Volunteers

417 people

Sponsor

Eli Lilly and Company